bristol-myers-squibb

Médias

European Researchers Invited to Submit Study Proposals for Bristol-Myers Squibb's Partnering for Cure™ Virology Research Programme

Médias

YERVOY®(ipilimumab) Receives Marketing Authorisation for First-Line Treatment of Adult Patients with Advanced Melanoma in Europe

Médias

Subcutaneous Formulation of ORENCIA® (abatacept) Approved by European Commission

Médias

New Four- and Five-Year Survival Data for YERVOY® (ipilimumab) in Treatment-Naïve and Previously-Treated Metastatic Melanoma Presented at the ESMO 2012 Congress (European Society for Medical Oncology)

Médias

World Hepatitis Alliance (the Alliance), European Liver Patient Association (ELPA) and Bristol-Myers Squibb Announce Global Expansion of PATH B Programme on World Hepatitis Day to Address the Unmet Need in Resources for People Living with Chronic Hepatitis B

Médias

ORENCIA® ▼ (abatacept) Demonstrates Comparable Efficacy to Humira® (adalimumab) in Patients with Moderate to Severe Rheumatoid Arthritis in First Head-to-Head Study of These Agents